Carregant...
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study
BACKGROUND: There are limited long-term outcome data in eculizumab-treated patients with atypical hemolytic uremic syndrome (aHUS). We report final results from the largest prospective, observational, multicenter study of patients with aHUS treated with eculizumab. METHODS: Patients with aHUS who pa...
Guardat en:
| Publicat a: | BMC Nephrol |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6456946/ https://ncbi.nlm.nih.gov/pubmed/30971227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1314-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|